Investors

Growth Strategy

Three Growth Strategies

At TSO₃ we are pursuing three distinct growth strategies to drive value for the industry and our shareholders:

1. Support the global introduction and commercialization of our newest product sold by 3M™ as the 3M™ Optreoz™ 125-Z Low Temperature Sterilizer:
   • Support introduction in 15 markets in the second half of 2011
   • Support 22 additional markets* in 2012
2. Broaden the portfolio with the development and commercialization of new products:
   • Purpose-built or sterilizer products
   • Geographic iterations of existing systems for local market acceleration
3. Acquire complimentary technology or product lines
   • Focus on the Healthcare Sterile Reprocessing market segment

TSO₃ continues to evaluate its manufacturing operations and options to obtain the highest quality systems assembled at the lowest possible cost.

* Will include US market upon regulatory clearance.